Report Detail
Global Biosimilar Market Professional Survey Report 2019
- RnM3751892 |
- 16 September, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference product. Biosimilar products are made of complex molecules with high molecular weight produced through genetic engineering in living cells. Biologics drugs are costlier than respective chemical drugs. Biosimilar drugs can save around 30 to 40 % in terms of price relative to the respective biologics drugs. Biosimilars are useful for the treatment of illnesses such as anemia, autoimmune diseases, cancer, diabetes, growth hormone deficiencies, hematological diseases, kidney failure, rheumatoid arthritis and others. For the manufacturing of biosimilars, manufacturers have to develop environments that are ideal for the living cells, which remain sensitive to environmental conditions. Moreover, they need to develop distinctive process to entice the living cells for producing similar outcome to a prevalent biological treatment. The substitution of biological drugs with biosimilar drugs can save lot of money for public health care sector and patients. The regulatory authorities in developed nations are promoting biosimilar products.
The global Biosimilar market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of 25.0% during 2019-2025.
This report focuses on Biosimilar volume and value at global level, regional level and company level. From a global perspective, this report represents overall Biosimilar market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Biosimilar in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Biosimilar manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Allergan plc
BIOCAD
Biocon
BioXpress Therapeutics
Boehringer Ingelheim
Celltrion
Coherus BioSciences
Dr. Reddy’s Laboratories
Genor BioPharma
Intas Pharmaceuticals Limited
Novartis
Pfizer
Reliance Life Sciences
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Human Growth Hormones
Monoclonal Antibodies
Insulin
Peptides
Erythropoietin
Others
Segment by Application
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others
Table of Contents
Executive Summary
1 Industry Overview of Biosimilar
- 1.1 Definition of Biosimilar
- 1.2 Biosimilar Segment by Type
- 1.2.1 Global Biosimilar Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Human Growth Hormones
- 1.2.3 Monoclonal Antibodies
- 1.2.4 Insulin
- 1.2.5 Peptides
- 1.2.6 Erythropoietin
- 1.2.7 Others
- 1.3 Biosimilar Segment by Applications
- 1.3.1 Global Biosimilar Consumption Comparison by Applications (2014-2025)
- 1.3.2 Oncology
- 1.3.3 Chronic and Autoimmune Diseases
- 1.3.4 Growth Hormone Deficiency
- 1.3.5 Infectious Diseases
- 1.3.6 Others
- 1.4 Global Biosimilar Overall Market
- 1.4.1 Global Biosimilar Revenue (2014-2025)
- 1.4.2 Global Biosimilar Production (2014-2025)
- 1.4.3 North America Biosimilar Status and Prospect (2014-2025)
- 1.4.4 Europe Biosimilar Status and Prospect (2014-2025)
- 1.4.5 China Biosimilar Status and Prospect (2014-2025)
- 1.4.6 Japan Biosimilar Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Biosimilar Status and Prospect (2014-2025)
- 1.4.8 India Biosimilar Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Biosimilar
- 2.3 Manufacturing Process Analysis of Biosimilar
- 2.4 Industry Chain Structure of Biosimilar
3 Development and Manufacturing Plants Analysis of Biosimilar
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Biosimilar Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Biosimilar
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Biosimilar Production and Capacity Analysis
- 4.2 Biosimilar Revenue Analysis
- 4.3 Biosimilar Price Analysis
- 4.4 Market Concentration Degree
5 Biosimilar Regional Market Analysis
- 5.1 Biosimilar Production by Regions
- 5.1.1 Global Biosimilar Production by Regions
- 5.1.2 Global Biosimilar Revenue by Regions
- 5.2 Biosimilar Consumption by Regions
- 5.3 North America Biosimilar Market Analysis
- 5.3.1 North America Biosimilar Production
- 5.3.2 North America Biosimilar Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Biosimilar Import and Export
- 5.4 Europe Biosimilar Market Analysis
- 5.4.1 Europe Biosimilar Production
- 5.4.2 Europe Biosimilar Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Biosimilar Import and Export
- 5.5 China Biosimilar Market Analysis
- 5.5.1 China Biosimilar Production
- 5.5.2 China Biosimilar Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Biosimilar Import and Export
- 5.6 Japan Biosimilar Market Analysis
- 5.6.1 Japan Biosimilar Production
- 5.6.2 Japan Biosimilar Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Biosimilar Import and Export
- 5.7 Southeast Asia Biosimilar Market Analysis
- 5.7.1 Southeast Asia Biosimilar Production
- 5.7.2 Southeast Asia Biosimilar Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Biosimilar Import and Export
- 5.8 India Biosimilar Market Analysis
- 5.8.1 India Biosimilar Production
- 5.8.2 India Biosimilar Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Biosimilar Import and Export
6 Biosimilar Segment Market Analysis (by Type)
- 6.1 Global Biosimilar Production by Type
- 6.2 Global Biosimilar Revenue by Type
- 6.3 Biosimilar Price by Type
7 Biosimilar Segment Market Analysis (by Application)
- 7.1 Global Biosimilar Consumption by Application
- 7.2 Global Biosimilar Consumption Market Share by Application (2014-2019)
8 Biosimilar Major Manufacturers Analysis
- 8.1 Allergan plc
- 8.1.1 Allergan plc Biosimilar Production Sites and Area Served
- 8.1.2 Allergan plc Product Introduction, Application and Specification
- 8.1.3 Allergan plc Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 BIOCAD
- 8.2.1 BIOCAD Biosimilar Production Sites and Area Served
- 8.2.2 BIOCAD Product Introduction, Application and Specification
- 8.2.3 BIOCAD Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Biocon
- 8.3.1 Biocon Biosimilar Production Sites and Area Served
- 8.3.2 Biocon Product Introduction, Application and Specification
- 8.3.3 Biocon Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 BioXpress Therapeutics
- 8.4.1 BioXpress Therapeutics Biosimilar Production Sites and Area Served
- 8.4.2 BioXpress Therapeutics Product Introduction, Application and Specification
- 8.4.3 BioXpress Therapeutics Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Boehringer Ingelheim
- 8.5.1 Boehringer Ingelheim Biosimilar Production Sites and Area Served
- 8.5.2 Boehringer Ingelheim Product Introduction, Application and Specification
- 8.5.3 Boehringer Ingelheim Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Celltrion
- 8.6.1 Celltrion Biosimilar Production Sites and Area Served
- 8.6.2 Celltrion Product Introduction, Application and Specification
- 8.6.3 Celltrion Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Coherus BioSciences
- 8.7.1 Coherus BioSciences Biosimilar Production Sites and Area Served
- 8.7.2 Coherus BioSciences Product Introduction, Application and Specification
- 8.7.3 Coherus BioSciences Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Dr. Reddy’s Laboratories
- 8.8.1 Dr. Reddy’s Laboratories Biosimilar Production Sites and Area Served
- 8.8.2 Dr. Reddy’s Laboratories Product Introduction, Application and Specification
- 8.8.3 Dr. Reddy’s Laboratories Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Genor BioPharma
- 8.9.1 Genor BioPharma Biosimilar Production Sites and Area Served
- 8.9.2 Genor BioPharma Product Introduction, Application and Specification
- 8.9.3 Genor BioPharma Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Intas Pharmaceuticals Limited
- 8.10.1 Intas Pharmaceuticals Limited Biosimilar Production Sites and Area Served
- 8.10.2 Intas Pharmaceuticals Limited Product Introduction, Application and Specification
- 8.10.3 Intas Pharmaceuticals Limited Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Novartis
- 8.12 Pfizer
- 8.13 Reliance Life Sciences
9 Development Trend of Analysis of Biosimilar Market
- 9.1 Global Biosimilar Market Trend Analysis
- 9.1.1 Global Biosimilar Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Biosimilar Regional Market Trend
- 9.2.1 North America Biosimilar Forecast 2019-2025
- 9.2.2 Europe Biosimilar Forecast 2019-2025
- 9.2.3 China Biosimilar Forecast 2019-2025
- 9.2.4 Japan Biosimilar Forecast 2019-2025
- 9.2.5 Southeast Asia Biosimilar Forecast 2019-2025
- 9.2.6 India Biosimilar Forecast 2019-2025
- 9.3 Biosimilar Market Trend (Product Type)
- 9.4 Biosimilar Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Biosimilar Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Biosimilar. Industry analysis & Market Report on Biosimilar is a syndicated market report, published as Global Biosimilar Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Biosimilar market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
